BioSpace News Archive

Ionis Pharmaceuticals, Inc. today announced that Management will present a Company overview at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019 at 4:00 p.m. PT in San Francisco, CA.

Dr. Shigeru Saito Treats First Patient at Shonan Kamakura General Hospital

Results are expected in the second half of 2019

Morphic Therapeutic announced today that the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019.

Deciphera Pharmaceuticals, Inc. today announced that Michael D. Taylor, Ph.D., President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at 2:00 PM PT at the Westin St. Francis in San Francisco.

Viking Therapeutics, Inc. today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 11th Annual Biotech Showcase™, being held January 7-9, 2019 at the Hilton San Francisco Union Square in San Francisco.

Ascletis Pharma Inc. announces today that the investigational new drug application (IND) for its third HCV drug ASC21 was accepted by the National Medical Products Administration (NMPA).

Brooks Automation, Inc. announced today that the company will present at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel, San Francisco, CA. Steve Schwartz, President and Chief Executive Officer, and Lindon Robertson, Chief Financial Officer, will present on Thursday, January 10th at 7:30 a.m. Pacific Time.

Teva Pharmaceutical Industries Ltd. announced today that it has resolved its ongoing dispute with Amgen over Teva’s generic cinacalcet HCl product.

Two medical students awarded for standout participation in the Academy’s Minority Ophthalmology Mentoring program